{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T20:54:25Z","timestamp":1794344065077,"version":"4.9.0"},"publisher-location":"Boston, MA","reference-count":39,"publisher":"Springer US","isbn-type":[{"value":"9780387232256","type":"print"},{"value":"9780387232263","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005]]},"DOI":"10.1007\/0-387-23226-5_2","type":"book-chapter","created":{"date-parts":[[2006,11,21]],"date-time":"2006-11-21T03:00:56Z","timestamp":1164078056000},"page":"45-63","source":"Crossref","is-referenced-by-count":21,"title":["Transgenic Mouse Models for APP Processing and Alzheimer\u2019s Disease: Early and Late Defects"],"prefix":"10.1007","author":[{"given":"Tom","family":"van Dooren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilse","family":"Dewachter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Borghgraef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"van Leuven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"2_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00401-003-0796-9","volume":"107","author":"J. Attems","year":"2004","unstructured":"Attems J., Jellinger K.A., 2004, Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology \u2014 a pilot study. Acta Neuropathol. (Berl). 107: 83\u201390.","journal-title":"Acta Neuropathol. (Berl)"},{"key":"2_CR2","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S1474-4422(03)00530-1","volume":"2","author":"K. Blennow","year":"2003","unstructured":"Blennow K., Hampel H., 2003, CSF markers for incipient Alzheimer\u2019s disease. Lancet Neurol. 2: 605\u2013613.","journal-title":"Lancet Neurol"},{"key":"2_CR3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H. Braak","year":"1991","unstructured":"Braak H., Braak E., 1991, Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. (Berl) 82: 239\u2013259.","journal-title":"Acta Neuropathol. (Berl)"},{"key":"2_CR4","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/34910","volume":"391","author":"B. Strooper De","year":"1998","unstructured":"De Strooper B., Saftig P., Craessaerts K., Vanderstichele H., Guhde G., Annaert W., Von Figura K., Van Leuven F., 1998, Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391: 387\u2013390.","journal-title":"Nature"},{"key":"2_CR5","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/00019052-200008000-00002","volume":"13","author":"A. Delacourte","year":"2000","unstructured":"Delacourte A., Buee L., 2000, Tau pathology: a marker of neurodegenerative disorders. Curr. Opin. Neurol. 13: 371\u2013376.","journal-title":"Curr. Opin. Neurol."},{"key":"2_CR6","doi-asserted-by":"crossref","first-page":"6452","DOI":"10.1523\/JNEUROSCI.20-17-06452.2000","volume":"20","author":"I. Dewachter","year":"2000","unstructured":"Dewachter I., Van Dorpe J., Smeijers L., Gilis M., Kuiperi C., Laenen I., Caluwaerts N., Moechars D., Checler F., Vanderstichele H. and Van Leuven F., 2000, Aging increased amyloid peptide and caused amyloid plaques in brain of old APP\/V717I transgenic mice by a different mechanism than mutant presenilinl. J. Neurosc. 20: 6452\u20136458.","journal-title":"J. Neurosc."},{"key":"2_CR7","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1523\/JNEUROSCI.22-09-03445.2002","volume":"22","author":"I. Dewachter","year":"2002","unstructured":"Dewachter I., Reverse D., Caluwaerts N., Ris L., Kuiperi C., Van den Haute C., Spittaels K., Umans L., Serneels L., Thiry E., Moechars D., Mercken M., Godaux E., Van Leuven F., 2002, Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice. J. Neurosci.. 22: 3445\u20133453.","journal-title":"J. Neurosci."},{"key":"2_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S1474-4422(02)00188-6","volume":"1","author":"I. Dewachter","year":"2002","unstructured":"Dewachter I., Van Leuven F., 2002, Secretases as targets for the treatment of Alzheimer\u2019s disease: the prospects. Lancet Neurol.. 1: 409\u2013416.","journal-title":"Lancet Neurol."},{"key":"2_CR9","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1073\/pnas.94.6.2095","volume":"94","author":"J. Hardy","year":"1997","unstructured":"Hardy J., 1997, The Alzheimer family of diseases: many etiologies, one pathogenesis? Proc. Natl. Acad. Sci. USA 94: 2095\u20132097.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2_CR10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1034\/j.1600-0854.2003.00086_4_5.x","volume":"203","author":"P. May","year":"2003","unstructured":"May P. and Herz J., 2003, LDL Receptor-related proteins in Neurodevelopment. Traffic, 203: 291\u2013301.","journal-title":"Traffic"},{"key":"2_CR11","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/hmg\/9.6.979","volume":"9","author":"P. Heutink","year":"2000","unstructured":"Heutink P., 2000, Untangling tau-related dementia. Hum. Mol. Genet.. 9: 979\u2013986.","journal-title":"Hum. Mol. Genet."},{"key":"2_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1126\/science.274.5284.99","volume":"174","author":"K. Hsiao","year":"1996","unstructured":"Hsiao K., Chapman P., Nilsen S., Eckman C., Hariqaya Y., Younkin S., Yang F., Cole G., 1996, Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 174: 99\u2013102.","journal-title":"Science"},{"key":"2_CR13","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S1471-4914(02)02440-1","volume":"8","author":"E.M. Ingram","year":"2002","unstructured":"Ingram E.M., Spillantini M.G., 2002, Tau gene mutations: dissecting the pathogenesis of FTDP-17. Trends Mol. Med. 8: 555\u2013562.","journal-title":"Trends Mol. Med."},{"key":"2_CR14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s12031-002-0011-9","volume":"19","author":"L.W. Jin","year":"2002","unstructured":"Jin L.W., Hua D.H., Shie F.S., Maezawa I., Sopher B., Martin G.M., 2002, Novel tricyclic pyrone compounds prevent intracellular APP C99-induced cell death. J. Mol. Neurosci.. 19: 57\u201361.","journal-title":"J. Mol. Neurosci."},{"key":"2_CR15","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1073\/pnas.94.4.1550","volume":"94","author":"K. Johnson-Wood","year":"1997","unstructured":"Johnson-Wood K., Lee M., Motter R., Hu K., Gordon G., Barbour R., Khan K., Gordon M. Tan H., Games D., Lieberburg I., Schenk D., Seubert P., McConlogue L., 1997, Amyloid precursor protein processing and Abeta42 deposition in a transgenic mouse model of Alzheimer disease. Proc. Natl. Acad. Sci. USA 94: 1550\u20131555.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2_CR16","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1126\/science.1058189","volume":"293","author":"J. Lewis","year":"2001","unstructured":"Lewis J., Dickson D.W., Lin W.L., Chisholm L., Corral A., Jones G., Yen S.H., Sahara N., Skipper L., Yager D., Eckman C., Hardy J., Hutton M., McGowan E., 2001, Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293: 1487\u20131491.","journal-title":"Science"},{"key":"2_CR17","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1046\/j.1471-4159.1999.0722479.x","volume":"72","author":"Q.X. Li","year":"1999","unstructured":"Li Q.X., Maynard C., Cappai R., McLean C.A., Cherny R.A., Lynch T., Culvenor J.G., Trevaskis J., Tanner J.E., Bailey K.A., Czech C., Bush A.I., Beyreuther K., Masters C.L., 1999, Intracellular accumulation of detergent-soluble amyloidogenic A beta fragment of Alzheimer\u2019s disease precursor protein in the hippocampus of aged transgenic mice. J. Neurochem.. 72: 2479\u20132787.","journal-title":"J. Neurochem."},{"key":"2_CR18","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1021\/bi015800g","volume":"41","author":"K. Liu","year":"2002","unstructured":"Liu K., Doms R.W. and Lee V.M.Y., 2002, Glul 1 site cleavage and N-terminally truncated A\u03b2 production upon BACE overexpression. Biochemistry 41: 3128\u20133136.","journal-title":"Biochemistry"},{"key":"2_CR19","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/j.1460-2075.1996.tb00468.x","volume":"15","author":"D. Moechars","year":"1996","unstructured":"Moechars D., Lorent K., De Strooper B., Dewachter I. and Van Leuven F., 1996, Expression in brain of amyloid precursor protein mutated in the \u03b1-secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice. EMBO J. 15: 1265\u20131274.","journal-title":"EMBO J"},{"key":"2_CR20","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1097\/00001756-199811160-00004","volume":"9","author":"D. Moechars","year":"1998","unstructured":"Moechars D., Gilis M., Kuiperi C. Laenen I., Van Leuven F., 1998, Aggressive behaviour in transgenic mice expressing APP is alleviated by serotonergic drugs. NeuroReport 9: 3561\u20133564.","journal-title":"NeuroReport"},{"key":"2_CR21","doi-asserted-by":"publisher","first-page":"6483","DOI":"10.1074\/jbc.274.10.6483","volume":"274","author":"D. Moechars","year":"1999","unstructured":"Moechars D., Dewachter I., Lorent K., Revers\u00e9 D., Baekelandt V., Naidu A., Tesseur I., Spittaels K., Van Den Haute C., Checler F., Godaux E., Cordell B. and Van Leuven F., 1999a, Early phenotypic changes in transgenic mice that overexpress different mutants of Amyloid Precursor Protein in brain. J. Biol. Chem. 274: 6483\u20136492.","journal-title":"J. Biol. Chem."},{"key":"2_CR22","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S0306-4522(98)00599-5","volume":"91","author":"D. Moechars","year":"1999","unstructured":"Moechars D., Lorent K., and Van Leuven F., 1999b, Premature death in transgenic mice that overexpress mutant Amyloid precursor protein is preceded by severe neurodegeneration and apoptosis. Neuroscience 91: 819\u2013830, 1999.","journal-title":"Neuroscience"},{"key":"2_CR23","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1385\/JMN:13:1-2:159","volume":"13","author":"W.A. Pedersen","year":"1999","unstructured":"Pedersen W.A., Culmsee C., Ziegler D., Herman J.P., and Mattson M.P., 1999, Aberrant stress response associated with severe hypoglycemia in a transgenic mouse model of Alzheimer\u2019s disease. J. Mol. Neurosci. 13: 159\u2013165.","journal-title":"J. Mol. Neurosci."},{"key":"2_CR24","doi-asserted-by":"crossref","unstructured":"Postina R., Schroeder A., Dewachter I., Bohl J., Schmitt U., Kojro E., Prinzen C., Endres K., Hiemke C., Blessing M., Flamez P., Dequenne A., Godaux E., Van Leuven F., Fahrenholz F., 2004, A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer\u2019s disease mouse model. J. Clin. Invest, in press.","DOI":"10.1172\/JCI200420864"},{"key":"2_CR25","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/BF03402043","volume":"9","author":"A.E. Roher","year":"2003","unstructured":"Roher A.E., Kuo Y.M., Esh C., Knebel C., Weiss N., Kalback W., Luehrs Childress J.L., Beach T.G., Weller R.O., Kokjohn T.A., 2003, Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer\u2019s disease. Mol. Med.. 9: 112\u201322.","journal-title":"Mol. Med."},{"key":"2_CR26","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","volume":"81","author":"D.J. Selkoe","year":"2001","unstructured":"Selkoe D.J., 2001, Alzheimer\u2019s disease: genes, proteins, and therapy. Physiol. Rev. 81: 741\u2013766.","journal-title":"Physiol. Rev."},{"key":"2_CR27","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1126\/science.1074069","volume":"298","author":"D.J. Selkoe","year":"2002","unstructured":"Selkoe D.J., 2002, Alzheimer\u2019s disease is a synaptic failure. Science. 298: 789\u2013791.","journal-title":"Science"},{"key":"2_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.2000.tb05552.x","volume":"924","author":"P.H. St. George-Hyslop","year":"2000","unstructured":"St. George-Hyslop P.H., 2000, Genetic factors in the genesis of Alzheimer\u2019s Disease. Ann. N. Y. Acad. Sci. 924: 1\u20137.","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"2_CR29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1385\/NMM:2:2:151","volume":"2","author":"D. Terwel","year":"2002","unstructured":"Terwel D., Dewachter L., Van Leuven F., 2002, Axonal transport, tau protein, and neurodegeneration in Alzheimer\u2019s disease. Nenromolecular Med. 2: 151\u2013165.","journal-title":"Nenromolecular Med"},{"key":"2_CR30","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0002-9440(10)64788-8","volume":"157","author":"I. Tesseur","year":"2000","unstructured":"Tesseur I., Van Dorpe J., Bruynseels K., Bronfman F., Sciot R., Van Lommel A., Van Leuven F., 2000, Prominent axonopathy and disruption of axonal transport in transgenic mice expressing human apolipoprotein E4 in neurons of brain and spinal cord. Am. J. Pathol. 157: 1495\u20131510.","journal-title":"Am. J. Pathol."},{"key":"2_CR31","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0002-9440(10)64963-2","volume":"156","author":"I. TesseUr","year":"2000","unstructured":"TesseUr I., Van Dorpe J., Spittaels K., Van den Haute C., Moechars D., Van Leuven F., 2000, Expression of human apolipoprotein E4 in neurons causes hyperphosophorylation of protein tau in the brains of transgenic mice. Am. J. Pathol. 156: 951\u2013964.","journal-title":"Am. J. Pathol."},{"key":"2_CR32","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.neulet.2003.08.048","volume":"352","author":"J. Tian","year":"2003","unstructured":"Tian J., Shi J., Bailey K., Mann D.M., 2003, Negative association between amyloid plaques and cerebral amyloid angiopathy in Alzheimer\u2019s disease. Neurosci. Lett. 352: 137\u2013140.","journal-title":"Neurosci. Lett."},{"key":"2_CR33","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0002-9440(10)64644-5","volume":"157","author":"J. Dorpe Van","year":"2000","unstructured":"Van Dorpe J., Smeijers L., Dewachter I., Buyers D., Spittaels K., Van den Haute C., Mercken M., Moechars D., Laenen I., Kuiperi C., Bruynseels K., Tesseur I., Loos R., Vanderstichele H., Checler F., and Van Leuven F., 2000, Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the London mutant of human APP in neurons. Am. J. Pathoi. 157: 1283\u201398.","journal-title":"Am. J. Pathoi."},{"key":"2_CR34","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1523\/JNEUROSCI.20-05-01657.2000","volume":"20","author":"K. Vekrellis","year":"2000","unstructured":"Vekrellis K., Ye Z., Qiu W.Q., Walsh D., Hartley D., Chesneau V., Rosner M.R., Selkoe D.J., 2000, Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme. J. Neurosci. 20: 1657\u20131665.","journal-title":"J. Neurosci."},{"key":"2_CR35","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0002-9440(10)65616-7","volume":"153","author":"R.O. Weller","year":"1998","unstructured":"Weller R.O., Massey A., Newman T.A., Hutchings M., Kuo Y.M. and Roher A.E., 1998, Amyloid \u03b2 accumulates in putative interstitial fluid drainage pathways in Alzheimer\u2019s Disease. Am. J. Pathol. 153: 725\u2013733.","journal-title":"Am. J. Pathol."},{"key":"2_CR36","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1179\/016164103101202057","volume":"25","author":"R.O. Weller","year":"2003","unstructured":"Weller R.O. and Nicoll J.A., 2003, Cerebral amyloid angiopathy: pathogenesis and effects on the ageing and Alzheimer brain. Neurol. Res. 25: 611\u2013616.","journal-title":"Neurol. Res."},{"key":"2_CR37","doi-asserted-by":"crossref","unstructured":"Willem M., Dewachter I., Smyth N., Van Dooren T., Borghgraef P., Haass C., Van Leuven F., 2004, BACE-1 increases amyloid deposition in brain parenchym but reduces cerebrovascular amyloid angiopathy in BACE \u00d7 APP[V717I] double transgenic mice. Submitted.","DOI":"10.1016\/S0002-9440(10)63419-0"},{"key":"2_CR38","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/387288a0","volume":"387","author":"P.C. Wong","year":"1997","unstructured":"Wong P.C., Zheng H., Chen H., Becher M.W., Sirinathsinghji D.J., Trumbauer M.E., Chen H.Y., Price D.L., Van der Ploeg L.H., Sisodia S.S., 1997, Presenilin 1 is required for Notch 1 and DIIl expression in the paraxial mesoderm. Nature 387: 288\u2013292.","journal-title":"Nature"},{"key":"2_CR39","doi-asserted-by":"publisher","first-page":"12876","DOI":"10.1074\/jbc.M311652200","volume":"279","author":"G.T. Wong","year":"2004","unstructured":"Wong G.T., Manfra D., Poulet F.M., Zhang Q., Josien H., Bara T., Engstrom L., Pinzon-Ortiz M., Fine J.S., Lee H.J., Zhang L., Higgins G.A., Parker E.M., 2004, Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation. J. Biol. Chem. 279:12876\u201312882.","journal-title":"J. Biol. Chem."}],"container-title":["Subcellular Biochemistry","Alzheimer\u2019s Disease"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/0-387-23226-5_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T08:05:43Z","timestamp":1555920343000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/0-387-23226-5_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"ISBN":["9780387232256","9780387232263"],"references-count":39,"URL":"https:\/\/doi.org\/10.1007\/0-387-23226-5_2","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/b100942","asserted-by":"object"}]},"ISSN":["0306-0225"],"issn-type":[{"value":"0306-0225","type":"print"}],"subject":[],"published":{"date-parts":[[2005]]}}}